Regulators adopt more orphan drugs

Sara Reardon

Nature, 2014, vol. 508, issue 7494, 16-17

Abstract: Agencies face rising applications for rare-disease therapies resulting from increasingly precise disease definitions.

Date: 2014
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/508016a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:508:y:2014:i:7494:d:10.1038_508016a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/508016a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().